Search - tctmd.com

Displaying 461 - 480 of 1046

Sort: Relevancy | Date

Presentation TCT 2018

TCT-46: Mitral Valve Gradient, Heart Failure Admissions and One Year Mortality Following MitraClip Repair in 5,378 Patients: Results from the ACC/STS TVT Registry

Presenter: Eric A. Cohen, Brij Maini, Lowie Van Assche

September 21, 2018

Presentation TCT 2018

Transcatheter Polymeric Pulmonary Valve for Congenital Heart Disease Applications (PolyVascular)

Presenter: Henri Justino

September 21, 2018

Presentation TCT 2018

Overview of the Watchman Procedure and Complications

Presenter: Martina Kelly Speight, David P. Lee

September 21, 2018

Presentation TCT 2018

Endogenous Leaflet Restoration Technology (Xeltis) Status Update for Aortic Valve Replacement Therapy

Presenter: Christian M. Spaulding

September 21, 2018

Presentation TCT 2018

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

Presenter: David Hildick-Smith, Martin B. Leon, Ulrich Schäfer

September 21, 2018

Presentation TCT 2018

TCT-45: Quality of Life Outcomes after Transcatheter Mitral Valve Repair in an Unselected Population. A Report from the STS/ACC TVT RegistryTM

Presenter: Eric A. Cohen, Brij Maini, Suzanne V. Arnold

September 21, 2018

Presentation TCT 2018

Anatomical Considerations for Patient Selection

Presenter: Martina Kelly Speight, Asma Hussaini

September 21, 2018

Presentation TCT 2018

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Presenter: Tamim Nazif

September 21, 2018

Presentation TCT 2018

Full Body Embolic Protection During TAVR (Filterlex)

Presenter: Giora Weisz

September 21, 2018

Presentation TCT 2018

TCT-20: Left Ventricular Fluid Dynamics Simulation for Transcatheter Mitral Valve Replacement

Presenter: Eric Eeckhout, Glenn Van Langenhove, James Otton

September 21, 2018

Presentation TCT 2018

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Presenter: Charles J. Davidson, Jeffrey J. Popma, Matthew Summers

September 21, 2018

Presentation TCT 2018

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Presenter: Jaffar M Khan

September 21, 2018

Presentation TCT 2018

Featured Lecture: Future Innovation in TAVR: Remaining Clinical Needs, Novel Technologies and Ancillary Device Strategies

Presenter: Dariusz Dudek, Ran Kornowski, Axel Linke, Martin B. Leon

September 21, 2018

Presentation TCT 2018

TCT-19: Predicting TMVR-Related LVOT Obstruction: Concept of Fluid Mechanics Modeling

Presenter: Eric Eeckhout, Glenn Van Langenhove, Keshav Kohli

September 21, 2018

Presentation TCT 2018

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

Presenter: Charles J. Davidson, Jeffrey J. Popma, Michael J. Reardon

September 21, 2018

Presentation TCT 2018

TCT-18: Novel Concept Of Catheter-Based Treatment For Tricuspid Regurgitation (Cerclage-TR Block): A Preliminary Animal Experiment in a Swine Model

Presenter: Eric Eeckhout, Glenn Van Langenhove, Min-Ku Chon

September 21, 2018

Presentation TCT 2018

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Presenter: Charles J. Davidson, Jeffrey J. Popma, Nicolas Dumontiel

September 21, 2018

Presentation TCT 2018

Update of the NeoVas BRS Clinical Trials

Presenter: Runlin Gao, Martin B. Leon, Yaling Han

September 21, 2018

Presentation TCT 2018

The Endpoints for Translational Mitral/Tricuspid Valve Development

Presenter: Robert O. Bonow, John C Laschinger, Blase A. Carabello

September 21, 2018

Presentation TCT 2018

TCT-17: Tricuspid Valve Regurgitation Reduction Following Concomitant Subvalvular and Annulus-Level Treatment Ex-Vivo Study

Presenter: Eric Eeckhout, Glenn Van Langenhove, Michal Jaworek

September 21, 2018

Advertisement

TCT-46: Mitral Valve Gradient, Heart Failure Admissions and One Year Mortality Following MitraClip Repair in 5,378 Patients: Results from the ACC/STS TVT Registry

Transcatheter Polymeric Pulmonary Valve for Congenital Heart Disease Applications (PolyVascular)

Overview of the Watchman Procedure and Complications

Endogenous Leaflet Restoration Technology (Xeltis) Status Update for Aortic Valve Replacement Therapy

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

TCT-45: Quality of Life Outcomes after Transcatheter Mitral Valve Repair in an Unselected Population. A Report from the STS/ACC TVT RegistryTM

Anatomical Considerations for Patient Selection

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Full Body Embolic Protection During TAVR (Filterlex)

TCT-20: Left Ventricular Fluid Dynamics Simulation for Transcatheter Mitral Valve Replacement

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Featured Lecture: Future Innovation in TAVR: Remaining Clinical Needs, Novel Technologies and Ancillary Device Strategies

TCT-19: Predicting TMVR-Related LVOT Obstruction: Concept of Fluid Mechanics Modeling

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

TCT-18: Novel Concept Of Catheter-Based Treatment For Tricuspid Regurgitation (Cerclage-TR Block): A Preliminary Animal Experiment in a Swine Model

TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve

Update of the NeoVas BRS Clinical Trials

The Endpoints for Translational Mitral/Tricuspid Valve Development

TCT-17: Tricuspid Valve Regurgitation Reduction Following Concomitant Subvalvular and Annulus-Level Treatment Ex-Vivo Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content